Earnings Call · Q4 FY2024·2024-08-27

Q4 24EPS -41.67%·Rev n/aQ3 24EPS +100.00%*·Rev n/aQ2 24EPS +43.48%·Rev n/aQ1 24EPS -100.00%*·Rev n/a⚠ consensus missing

LIFECORE BIOMEDICAL, INC. DE LFCR

Stephanie Diaz — Investor Relations

Paul Josephs — President and Chief Executive Officer

John D. Morberg — Chief Financial Officer

+5.7%1d on move date+5.9% vs SPY3d−33.8%5d−27.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LFCR calls or request research access.

More LFCR calls Browse calls Request research access